M 702 (Rizatriptan benzoate (orally disintegrating) 10 mg (base))
Pill imprint M 702 has been identified as Rizatriptan benzoate (orally disintegrating) 10 mg (base).
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 10 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
More about rizatriptan
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.